Literature DB >> 20211271

Quantitative mapping of T1 and T2* discloses nigral and brainstem pathology in early Parkinson's disease.

Simon Baudrexel1, Lucas Nürnberger, Udo Rüb, Carola Seifried, Johannes C Klein, Thomas Deller, Helmuth Steinmetz, Ralf Deichmann, Rüdiger Hilker.   

Abstract

Quantitative magnetic resonance imaging is a promising in vivo imaging technique revealing insights into different aspects of brain morphology in neurodegenerative diseases based on the determination of physical tissue parameters. Using combined T1- and T2*-mapping, we investigated changes of local relaxation times in the midbrain and lower brainstem of 20 patients with early Parkinson's disease (PD) compared to 20 healthy controls. Voxelwise statistical parametric mapping disclosed a widespread reduction of midbrain T1 values contralateral to the clinically more severely affected limbs. Within the SN, the T1 decrease matched the known pattern of selective neuronal loss as examined in various post-mortem studies, suggesting that T1 is a marker for PD related tissue pathology. However, the spatial extent of T1 reductions exceeded the SN and reached non-dopaminergic areas in the pontomesencephalic junction potentially involved in early non-motor symptoms of PD. In contrast, T2*-mapping revealed a bilateral decrease of T2* values restricted to the SN, indicating a local increase in total iron content. We conclude that, particularly in longitudinal studies, quantitative T1 may be a valuable marker for the monitoring of progressive neuronal loss in PD, whereas nigral T2* reductions might be more closely associated with an increased general vulnerability for the development of the disorder. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20211271     DOI: 10.1016/j.neuroimage.2010.03.005

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  53 in total

1.  Correlation between neuromelanin-sensitive MR imaging and (123)I-FP-CIT SPECT in patients with parkinsonism.

Authors:  Keita Kuya; Yuki Shinohara; Fuminori Miyoshi; Shinya Fujii; Yoshio Tanabe; Toshihide Ogawa
Journal:  Neuroradiology       Date:  2016-01-16       Impact factor: 2.804

2.  To measure T1 of short T2 species using an inversion recovery prepared three-dimensional ultrashort echo time (3D IR-UTE) method: A phantom study.

Authors:  Zhao Wei; Ya-Jun Ma; Hyungseok Jang; Wenhui Yang; Jiang Du
Journal:  J Magn Reson       Date:  2020-04-13       Impact factor: 2.229

3.  Accurate T1 mapping of short T2 tissues using a three-dimensional ultrashort echo time cones actual flip angle imaging-variable repetition time (3D UTE-Cones AFI-VTR) method.

Authors:  Ya-Jun Ma; Xing Lu; Michael Carl; Yanchun Zhu; Nikolaus M Szeverenyi; Graeme M Bydder; Eric Y Chang; Jiang Du
Journal:  Magn Reson Med       Date:  2018-01-03       Impact factor: 4.668

Review 4.  [Early recognition of Parkinson's disease. Objectifiable non-motor symptoms and biomarkers].

Authors:  B Mollenhauer; F Sixel-Döring; A Storch; C Schneider; R Hilker; E Kalbe
Journal:  Nervenarzt       Date:  2013-08       Impact factor: 1.214

5.  Magnetic resonance T1w/T2w ratio: A parsimonious marker for Parkinson disease.

Authors:  Guangwei Du; Mechelle M Lewis; Christopher Sica; Lan Kong; Xuemei Huang
Journal:  Ann Neurol       Date:  2018-12-19       Impact factor: 10.422

6.  Direct and accelerated parameter mapping using the unscented Kalman filter.

Authors:  Li Zhao; Xue Feng; Craig H Meyer
Journal:  Magn Reson Med       Date:  2015-06-03       Impact factor: 4.668

7.  Usefulness of quantitative susceptibility mapping for the diagnosis of Parkinson disease.

Authors:  Y Murakami; S Kakeda; K Watanabe; I Ueda; A Ogasawara; J Moriya; S Ide; K Futatsuya; T Sato; K Okada; T Uozumi; S Tsuji; T Liu; Y Wang; Y Korogi
Journal:  AJNR Am J Neuroradiol       Date:  2015-03-12       Impact factor: 3.825

8.  T2* mapping with background gradient correction using different excitation pulse shapes.

Authors:  N M Hirsch; C Preibisch
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-26       Impact factor: 3.825

Review 9.  Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies.

Authors:  Adriane Gröger; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2012-08-09       Impact factor: 3.575

Review 10.  Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.

Authors:  Xiaojun Guan; Xiaojun Xu; Minming Zhang
Journal:  Neurosci Bull       Date:  2017-05-17       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.